Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study. [PDF]
Short NJ +20 more
europepmc +1 more source
Common ancestral origin of indeterminate dendritic cell tumor and chronic myelomonocytic leukemia in clonal hematopoiesis. [PDF]
Sato A +10 more
europepmc +1 more source
ALK-positive histiocytosis and a clonally related chronic myelomonocytic leukemia. [PDF]
Breimer GE +9 more
europepmc +1 more source
Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
Abdulgayoom M +7 more
europepmc +1 more source
Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia. [PDF]
Montalban-Bravo G +31 more
europepmc +1 more source
IgA vasculitis associated with chronic myelomonocytic leukemia. [PDF]
Rouvière B +6 more
europepmc +1 more source
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of <i>Nras</i> <sup>G12D</sup>-driven chronic myelomonocytic leukemia. [PDF]
Li Y +11 more
europepmc +1 more source
Concomitant plasma cell myeloma and chronic myelomonocytic leukemia in elderly: diagnostic complexity, therapeutic challenges - case report and literature review. [PDF]
Rohita DK +8 more
europepmc +1 more source
Clinical perception and novel insights of chronic myelomonocytic leukemia: a 10-year multi-center retrospective study. [PDF]
Liu Y +8 more
europepmc +1 more source
A case of delayed-onset postoperative pyoderma gangrenosum complicated with chronic myelomonocytic leukemia treated with systemic corticosteroids and spesolimab. [PDF]
Zhenni G +6 more
europepmc +1 more source

